Gjesing Anette P, Hornbak Malene, Allin Kristine H, Ekstrøm Claus T, Urhammer Søren A, Eiberg Hans, Pedersen Oluf, Hansen Torben
The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Universitetsparken 1-3, 2100, Copenhagen Ø, Denmark,
Diabetologia. 2014 Jun;57(6):1173-81. doi: 10.1007/s00125-014-3207-y. Epub 2014 Mar 7.
AIMS/HYPOTHESIS: The aim of this study was to estimate the heritability of quantitative measures of glucose regulation obtained from a tolbutamide-modified frequently sampled IVGTT (t-FSIGT) and to correlate the heritability of the glucose-stimulated beta cell response to the tolbutamide-induced beta cell response. In addition, single nucleotide polymorphisms (SNPs) having an exclusive effect on either glucose- or tolbutamide-stimulated insulin release were identified.
Two hundred and eighty-four non-diabetic family members of patients with type 2 diabetes underwent a t-FSIGT with intravenous injection of glucose at t = 0 min and tolbutamide at t = 20 min. Measurements of plasma glucose, serum insulin and serum C-peptide were taken at 33 time points from fasting to 180 min. Insulin secretion rate, acute insulin response (AIR), disposition index (DI) after glucose and disposition index after tolbutamide (DIT), insulin sensitivity (SI), glucose effectiveness (SG) and beta cell responsiveness to glucose were calculated. A polygenic variance component model was used to estimate heritability, genetic correlations and associations.
We found high heritabilities for acute insulin secretion subsequent to glucose stimulation (AIRglucose h (2) ± SE: 0.88 ± 0.14), but these were slightly lower after tolbutamide (AIRtolbutamide h (2) ± SE: 0.69 ± 0.14). We also estimated the heritabilities for SI (h (2) ± SE: 0.26 ± 0.12), SG (h (2) ± SE: 0.47 ± 0.13), DI (h (2) ± SE: 0.56 ± 0.14), DIT (h (2) ± SE: 0.49 ± 0.14) and beta cell responsiveness to glucose (h (2) ± SE: 0.66 ± 0.12). Additionally, strong genetic correlations were found between measures of beta cell response after glucose and tolbutamide stimulation, with correlation coefficients ranging from 0.77 to 0.88. Furthermore, we identified five SNPs with an exclusive effect on either glucose-stimulated (rs5215, rs1111875, rs11920090) or tolbutamide-stimulated (rs10946398, rs864745) insulin secretion.
CONCLUSIONS/INTERPRETATION: Our data demonstrate that both glucose- and tolbutamide-induced insulin secretions are highly heritable traits, which are largely under the control of the same genes.
目的/假设:本研究旨在评估从甲苯磺丁脲改良的频繁采样静脉葡萄糖耐量试验(t-FSIGT)中获得的葡萄糖调节定量指标的遗传力,并将葡萄糖刺激的β细胞反应的遗传力与甲苯磺丁脲诱导的β细胞反应相关联。此外,还鉴定了对葡萄糖或甲苯磺丁脲刺激的胰岛素释放有独特影响的单核苷酸多态性(SNP)。
284名2型糖尿病患者的非糖尿病家庭成员接受了t-FSIGT,在t = 0分钟静脉注射葡萄糖,在t = 20分钟静脉注射甲苯磺丁脲。从空腹到180分钟的33个时间点测量血浆葡萄糖、血清胰岛素和血清C肽。计算胰岛素分泌率、急性胰岛素反应(AIR)、葡萄糖后处置指数(DI)和甲苯磺丁脲后处置指数(DIT)、胰岛素敏感性(SI)、葡萄糖效能(SG)以及β细胞对葡萄糖的反应性。使用多基因方差成分模型来估计遗传力、遗传相关性和关联性。
我们发现葡萄糖刺激后急性胰岛素分泌的遗传力较高(AIR葡萄糖h(2)±SE:0.88±0.14),但甲苯磺丁脲刺激后略低(AIR甲苯磺丁脲h(2)±SE:0.69±0.14)。我们还估计了SI(h(2)±SE:0.26±0.12)、SG(h(2)±SE:0.47±0.13)、DI(h(2)±SE:0.56±0.1)、DIT(h(2)±SE:0.49±0.14)和β细胞对葡萄糖的反应性(h(2)±SE:0.66±0.12)的遗传力。此外,发现葡萄糖和甲苯磺丁脲刺激后β细胞反应指标之间存在很强的遗传相关性,相关系数在0.77至0.88之间。此外,我们鉴定了五个对葡萄糖刺激(rs5215、rs1111875、rs11920090)或甲苯磺丁脲刺激(rs1)胰岛素分泌有独特影响的SNP。
结论/解读:我们的数据表明,葡萄糖和甲苯磺丁脲诱导的胰岛素分泌都是高度可遗传的性状,在很大程度上受相同基因的控制。